Invion Ltd Ord


By |


Invion Ltd a clinical-stage drug development company, develops treatments for respiratory and autoimmune disease. It develops products such as INV102 (nadolol), INV103 (ala-Cpn10) and INV104 (zafirlukast) for asthma and smoking cessation. The company has completed the Phase I studies with both intravenous and subcutaneous administration, and three intravenous dosing Phase II clinical trials in rheumatoid arthritis (RA), psoriasis and multiple sclerosis.

Contact Information

Main Phone: +61 390816005
Address: 722 High Street
Address 2: East Kew
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3102

Issuer Information

Exchange: OTO
Employees: 3
$ 0.01 $ 0. (0.00%)
Last Price 0.01 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.01
Last Trade Volume 0 52 Wk Hi 0.0372 52 Wk Low 0.01
Market Cap 54.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 5,492,272,967.00 EPS (TTM) 0.00 PE Ratio N/A Exchange OTCPK